Twist Bioscience Corporation
TWST
Clasificación en acciones
#2143
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Precio por acción
$144.87
Última sincronización: 2026-10-20
Capitalización bursátil
$9.54B
Cambio (1 día)
3.65%
Cambio (1 año)
333.86%
País
US
Comercio Twist Bioscience Corporation (TWST)
Categoría
Healthcare
Ingresos de Twist Bioscience Corporation (TWST)
Ingresos en Jun 2026 TTM: $431.80M
Según los últimos informes financieros de Twist Bioscience Corporation, los ingresos actuales de la empresa (TTM) son $431.80M. En 2024, la empresa obtuvo unos ingresos de $312.97M un aumento con respecto a los ingresos del año 2023, que fueron de $245.11M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Twist Bioscience Corporation desde 2016 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $431.80M | 14.67% |
| 2025 | $376.57M | 20.32% |
| 2024 | $312.97M | 27.69% |
| 2023 | $245.11M | 20.41% |
| 2022 | $203.57M | 53.83% |
| 2021 | $132.33M | 46.87% |
| 2020 | $90.10M | 65.67% |
| 2019 | $54.39M | 113.89% |
| 2018 | $25.43M | 136.16% |
| 2017 | $10.77M | 374.53% |
| 2016 | $2.27M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $46.34B | 10,630.94% |
US
|
|
| $25.11B | 5,714.52% |
US
|
|
| $2.71B | 526.93% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 1,607.28% |
US
|
